Alcimed assists its clients in carrying out due diligence, or strategic acquisition audits, to evaluate the value potential of a target company and its current and future risk areas in order to validate or correct an investment offer.
They trust us
How we support you to achieve a due diligence
We assist our clients in the examination of files for the acquisition or sale of companies. For our venture capital and industrial clients, we carry out strategic due diligence of their target, or strategic acquisition audits, in order to validate their business plan. The objective of a due diligence is to get a true and global radiography of the target: market context, current competition or new entrants, relevance of their strategic positioning, potential of their product launches, appropriateness of their commercial strategy and market approach, growth levers, etc. to confirm the key assumptions that support the levels of sales forecasts and validate the absence of “red flags”.
In the opposite direction, we also perform vendor due diligence, which aims to present a company to future investors or buyers with the same rigor of analysis of its business plan.
Examples of recent due diligences carried out for our clients
Due diligence for a start-up in the field of digital health
We helped a leading pharmaceutical company to evaluate the potential of a start-up company that had developed a new offering based on a connected bracelet for fertility measurement.
To do so, we performed a due diligence of the targeted start-up, analyzing in particular the user experience and the medical interest perceived by gynecologists for their product.
Our project validated our client’s interest in investing in the start-up and highlighted improvements in the marketing and commercialization of the device.
Strategic due diligence in the field of biopharmaceutical production
We assisted an investment fund in carrying out a strategic audit of a producer of stainless steel tanks in the biopharmaceutical and food-processing markets.
We assessed the manufacturer’s perception of its customers in both markets, and challenged the coherence between the offer and the market’s needs and expectations.
The evaluation of the development prospects in both sectors allowed us to confirm the interest of investing in this producer and to have visibility on the development potential in the next 5 years.
Vendor Due Diligence of a company specialized in medical devices for dependent elderly people
Our team assisted a company specializing in medical devices for the elderly in the preparation of a Vendor Due Diligence report with a view to a potential sale of its activities.
In order to present this investment opportunity to potential investors, Alcimed carried out a complete strategic audit: analysis of the potential market and of the market potential, customer segmentation, identification of market drivers and barriers, competitor analysis, regulatory analysis, critical opinion on the company’s 5-year business plan.
Our report summarized the opportunities and risks related to this investment, with neutrality, to inform the decision making of potential buyers.
Creation of a new due diligence process for a vaccine player
We supported a leading vaccine player in redesigning its current due diligence process to address several identified limitations: the absence of a common standard procedure for all, the lack of skills of some members involved and the lack of training program in place, the insufficient exhaustiveness in some parts of the risk analysis, or the lack of real-time sharing of progress on each business development project. In order to overcome these limitations, and to formalize a new set of standard procedures, our team has implemented a 4 key steps approach:
- A critical analysis of current practices
- A benchmark of the practices of other industrial players and investment funds
- The organization of a workshop to co-build the new process with the ‘due diligence’ team
- The development and sharing of key tools to be used in the process.
In the end, our project allowed our client to define a new standard for its due diligence exercises, with a trained and motivated team!
You have a project?
To go further
Founded in 1993, Alcimed is an innovation and new business consulting firm, specializing in innovation driven sectors: life sciences (healthcare, biotech, agrifood), energy, environment, mobility, chemicals, materials, cosmetics, aeronautics, space and defence.
Our purpose? Helping both private and public decision-makers explore and develop their uncharted territories: new technologies, new offers, new geographies, possible futures, and new ways to innovate.
Located across eight offices around the world (France, Europe, Singapore and the United States), our team is made up of 220 highly-qualified, multicultural and passionate explorers, with a blended science/technology and business culture.
Our dream? To build a team of 1,000 explorers, to design tomorrow’s world hand in hand with our clients.
Due diligence is an in-depth analysis of a target enabling companies and investors to make informed decisions about acquiring a company, with a full grasp of the opportunities, risks and strategic implications. Due diligence aims to analyze: the target company’s target market, competitors, financial health, assets, organizational aspects, corporate culture and level of risk.